[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor]

MeSH terms

• Anti-Bacterial Agents / administration & dosage
• Anti-Bacterial Agents / therapeutic use
• Antifungal Agents / administration & dosage
• Antifungal Agents / therapeutic use
• Ciprofloxacin / administration & dosage
• Ciprofloxacin / therapeutic use
• Drug Resistance, Multiple, Bacterial*
• Drug Therapy, Combination
• Female
• Fluconazole / administration & dosage
• Fluconazole / therapeutic use
• Glomerulonephritis, IGA / complications
• Glomerulonephritis, IGA / therapy
• Gram-Negative Bacterial Infections / drug therapy
• Gram-Negative Bacterial Infections / etiology*
• Humans
• Imipenem / administration & dosage
• Imipenem / therapeutic use
• Middle Aged
• Ochrobactrum anthropi / drug effects*
• Ochrobactrum anthropi / isolation & purification
• Peritoneal Dialysis / adverse effects*
• Peritonitis / drug therapy*
• Peritonitis / etiology
• Peritonitis / microbiology
• Pseudomonas Infections / complications
• Pseudomonas Infections / drug therapy